SBSD Stock Overview

Designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, European Union, and internationally. More details

SBSD fundamental analysis
Snowflake Score
Valuation	3/6
Future Growth	4/6
Past Performance	1/6
Financial Health	4/6
Dividends	2/6

Rewards

Trading at 43.9% below our estimate of its fair value

Earnings are forecast to grow 25.38% per year

Analysts in good agreement that stock price will rise by 37.8%

Risk Analysis

Shares are highly illiquid

Has a high level of debt

My Notes

Capture your thoughts, links and company narrative

Stratec SE Competitors

NIOX Group

AIM:NIOX

UK£250.7m

EKF Diagnostics Holdings

AIM:EKF

UK£122.7m

Smith & Nephew

LSE:SN.

UK£8.6b

Advanced Medical Solutions Group

AIM:AMS

UK£418.7m

Price History & Performance

Summary of share price highs, lows and changes for Stratec
Historical stock prices
Current Share Price	€33.15
52 Week High	€39.10
52 Week Low	€32.60
Beta	0.27
1 Month Change	1.69%
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	-72.60%
5 Year Change	-48.36%
Change since IPO	-37.80%

Recent updates

Shareholder Returns

	SBSD	GB Medical Equipment	GB Market
7D	0%	-0.4%	0.8%
1Y	n/a	-9.1%	4.4%

Return vs Industry: Insufficient data to determine how SBSD performed against the UK Medical Equipment industry.

Return vs Market: Insufficient data to determine how SBSD performed against the UK Market.

Price Volatility

Is SBSD's price volatile compared to industry and market?
SBSD volatility
SBSD Average Weekly Movement	n/a
Medical Equipment Industry Average Movement	6.6%
Market Average Movement	4.7%
10% most volatile stocks in GB Market	10.6%
10% least volatile stocks in GB Market	2.5%

Stable Share Price: SBSD's share price has been volatile over the past 3 months compared to the UK market.

Volatility Over Time: Insufficient data to determine SBSD's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2018	1,462	Marcus Wolfinger	www.stratec.com

Stratec SE, together with its subsidiaries, designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, European Union, and internationally. It designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers; and offers complex consumables for diagnostics and medical applications. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018.

Stratec SE Fundamentals Summary

How do Stratec's earnings and revenue compare to its market cap?
SBSD fundamental statistics
Market cap	€361.64m
Earnings (TTM)	€10.01m
Revenue (TTM)	€250.54m

36.1x

P/E Ratio

1.4x

P/S Ratio

Is SBSD overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
SBSD income statement (TTM)
Revenue	€250.54m
Cost of Revenue	€182.78m
Gross Profit	€67.75m
Other Expenses	€57.74m
Earnings	€10.01m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

Mar 27, 2025

Earnings per share (EPS)	0.82
Gross Margin	27.04%
Net Profit Margin	4.00%
Debt/Equity Ratio	67.0%

How did SBSD perform over the long term?

See historical performance and comparison

Dividends

1.8%

Current Dividend Yield

67%

Payout Ratio

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/01/05 15:29
End of Day Share Price	2024/12/12 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Stratec SE is covered by 19 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Volker Braun	Bankhaus Lampe KG
Odysseas Manesiotis	Berenberg
Scott Bardo	Berenberg

Stratec BATS-CHIXE:SBSD Stock Report